Changes In OTC Distribution In Europe

20 April 1997

While over-the-counter drug distribution varies in each of Europe's 15major markets, some common themes are emerging, says a new study from James Dudley Management.

The report says the nonprescription-bound drugs market has grown 33% since 1990 in the 15 countries, to a value of $15.6 billion at manufacturers' prices in 1996. Almost 90% of health care distribution flows through Europe's 220,000 pharmacies, compared with 45% in the USA. Retail pharmacies are the heart of the distribution system and, except for the Netherlands, are the primary source of purchase for OTCs. Common trends include:

- moves to abolish resale price maintenance on OTCs are underway in Germany, the Netherlands and the UK;

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight